LDL-Subfractions in Cholesterol Control

LDL-Subfractions in Cholesterol Control

LDL-Subfractions in Cholesterol Control

 

A New Paradigm in LDL-associated CVD significance

Cardiovascular Disease is the leading cause of death in both men and women worldwide.

Does high cholesterol mean a risk for cardiovascular diseases, heart attack, stroke?

Why is it important?

Half of myocardial infarctions occur in patients with no overt hyperlipidaemia, and 20% occur in the absence of any classic risk factor. 50% of people who suffer from coronary artery disease (CAD) have normal cholesterol levels indicates the need for a more specific diagnostic tool.

Plasma lipoprotein particles contain variable proportions of four major elements: cholesterol, triglycerides, phospholipids and specific proteins called apoproteins. The relationship between small dense LDL particles and an increased risk for CAD has been well established.
Evaluation of lipid sub-fractions in the role of CVD reveals key epidemiologic links to cardiovascular risk or the need for pharmaceutical statin interventions.
The anti-inflammatory or lipid-lowering effects of pharmacologic and nutritional therapies can further be elucidated with genetic polymorphisms and apo-lipoprotein markers.

Learning Outcomes

In this course webinar, you will learn:
• Differentiation and clinical significance of lipid markers
• Functional pathology approach to understanding biomarkers of CVD
• Genetic risk factors and markers
• Understanding a lab report
• Management of a cardiovascular patient

Introduction

Duration of video: 15:03 minutes

In this webinar, you will learn:

  • how big is CAD?
  • whats are the signs and symptons of cholesterol imbalance?
  • what are the causitive and risk factors?
  • what is dyslipidemia vs hypercholesteremia?
  • how does stress affect cholesterol?
  • do metal toxicities affect the heart?

CardioGenomics

Duration of video: 6:31 minutes

In this webinar, you will learn:

  • Cardiogenomics
  • Genetic factors
  • Predictive factors in cholesterol and CAD

Emerging Lab Markers

Duration of video: 28:23 minutes

In this webinar, you will learn:

  • Emerging Lab Markers in Coronory Artery disease (CAD)
  • Lab testing for Cholesterol LDL-subfractions
  • Apo-Lipoproteins
  • Lipoprotein A
  • Oxidised LDL
  • Coronory Calcium Score
  • Predictive and emerging lab markers
  • Inflammation markers

Management of Cholesterol

Duration of video: 27:13 minutes

In this webinar, you will learn;

  • Management of Cholestrol
  • pharmaceutical medication
  • natural medication

Case study

Duration of video: 6:18 minutes

In this webinar, you will learn:

Case Study

  • case study with natural medication interventions

 

This offering provides CPD continuing professional development credits for

ATMS Australian Traditional Medicine Society   Complementary Medicines Australia CMA